Prognostic factors and validation of prognostic nomograms in patients (pts) treated with three targeted therapies (TTs) for metastatic renal cell carcinoma (mRCC): Results from an Italian survey.
Roberto Iacovelli
No relevant relationships to disclose
Michele Milella
No relevant relationships to disclose
Matteo Santoni
No relevant relationships to disclose
Giuseppe Di Lorenzo
No relevant relationships to disclose
Cinzia Ortega
No relevant relationships to disclose
Roberto Sabbatini
No relevant relationships to disclose
Riccardo Ricotta
No relevant relationships to disclose
Vito Lorusso
No relevant relationships to disclose
Caterina Messina
No relevant relationships to disclose
Francesco Atzori
No relevant relationships to disclose
Paolo A. Zucali
No relevant relationships to disclose
Saverio Cinieri
No relevant relationships to disclose
Alessandra Mosca
No relevant relationships to disclose
Elena Verzoni
No relevant relationships to disclose
Francesca Primi
No relevant relationships to disclose
Chiara Baratelli
No relevant relationships to disclose
Enrico Cortesi
No relevant relationships to disclose
Giacomo Carteni
No relevant relationships to disclose
Cora N. Sternberg
No relevant relationships to disclose
Giuseppe Procopio
No relevant relationships to disclose